Literature DB >> 12010428

Rare coagulation deficiencies.

F Peyvandi1, S Duga, S Akhavan, P M Mannucci.   

Abstract

UNLABELLED: Deficiencies of coagulation factors (other than factor VIII and factor IX) that cause a bleeding disorder are inherited as autosomal recessive traits and are generally rare, with prevalences in the general population varying between 1 : 500 000 and 1 : 2 000 000. In the last few years, the number of patients with recessively transmitted coagulation deficiencies has increased in European countries with a high rate of immigration of Islamic populations, because in these populations, consanguineous marriages are frequent. Owing to the relative rarity of these deficiencies, the type and severity of bleeding symptoms, the underlying molecular defects and the actual management of bleeding episodes are not as well established as for haemophilia A and B. This article reviews these disorders in terms of their clinical manifestations and characterization of the molecular defects involved. The general principles of management are also discussed. KEYWORDS: afibrinogenaemia, autosomal recessive disorders, factor VIII, factor XI, factor XIII.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010428     DOI: 10.1046/j.1365-2516.2002.00633.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  32 in total

Review 1.  The genetic and molecular bases of monogenic disorders affecting proteolytic systems.

Authors:  I Richard
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

2.  Budd-Chiari syndrome in an afibrinogenemic patient: a paradoxical complication.

Authors:  Nevin Oruc; Yaman Tokat; Refik Killi; Murat Tombuloglu; Tankut Ilter
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

3.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

4.  Circumcision in patients with congenital factor X deficiency.

Authors:  Sinan Akbayram; Mesut Garipardic; Kamuran Karaman; Salim Bilici; Ahmet Faik Oner
Journal:  Indian J Pediatr       Date:  2014-06-29       Impact factor: 1.967

5.  Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.

Authors:  Qiulan Ding; Likui Yang; Xiaoqing Zhao; Wenman Wu; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

6.  [Hereditary heterozygous factor VII deficiency in patients undergoing surgery : Clinical relevance].

Authors:  D Woehrle; M Martinez; D Bolliger
Journal:  Anaesthesist       Date:  2016-09-01       Impact factor: 1.041

7.  The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.

Authors:  Qiulan Ding; Yiping Shen; Likui Yang; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

8.  Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.

Authors:  Qiuya Lu; Likui Yang; Chandrashekhara Manithody; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Res       Date:  2014-08-20       Impact factor: 3.944

Review 9.  National and international registries of rare bleeding disorders.

Authors:  Flora Peyvandi; Marta Spreafico
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 10.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.